Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Published in: European Journal of Clinical Microbiology & Infectious Diseases 9/2018

01-09-2018 | Review

How human microbiome talks to health and disease

Authors: Jing Cong, Xiaochun Zhang

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 9/2018

Login to get access

Abstract

Microbes are ubiquitous in the human body. They usually live in communities, and each of these communities has a distinct taxonomical structure. Due to its close relationship with human health and disease, the human microbiome has received great attention and is probably considered to be the most valuable biomarker in preventing and solving human diseases. In this paper, we first review the value of the human microbiome. Then, we focus on the role of the human microbiome in influencing human health and disease. Furthermore, we intensively discuss the relationship between intestinal microbiota and cancer therapy. Finally, we briefly summarize the significance of the human microbiome based on the development of sequencing and bioinformatic techniques.
Literature
1.
Fontaneto D, Hortal J (2012) Microbial biogeography: is everything small everywhere? Caister Academic Press, Poole, p 87–98
2.
Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA (2005) Diversity of the human intestinal microbial flora. Science 308(5728):1635–1638CrossRefPubMedPubMedCentral
3.
Grice EA, Segre JA (2012) The human microbiome: our second genome. Annual Rev Genomics Human Genetics 13(1):151–170CrossRef
4.
Dethlefsen L, Mcfallngai M, Relman DA (2007) An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 449(7164):811–818CrossRefPubMed
5.
Zhu GZ, Li JT (2008) Substantial alterations of the cutaneous bacterial biota in psoriatic lesions. PLoS One 3(7):550–550
6.
Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (7122):1027–1031
7.
Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R (2011) Bacterial community variation in human body habitats across space and time. Science 326(5960):1694–1697CrossRef
8.
Wei L, Lei H, Yu P, Ma C, Wu X, Xu J (2014) Nested PCR-denaturing gradient gel electrophoresis analysis of human skin microbial diversity with age. Microbiol Res 169(9–10):686–692
9.
Wylie KM, Mihindukulasuriya KA, Zhou Y, Sodergren E, Storch GA, Weinstock GM (2014) Metagenomic analysis of double-stranded DNA viruses in healthy adults. BMC Biol 12(1):1–10CrossRef
10.
Clavaud C, Jourdain R, Barhen A, Tichit M, Bouchier C, Pouradier F, Rawadi CE, Guillot J, Ménardszczebara F, Breton L (2013) Dandruff is associated with disequilibrium in the proportion of the major bacterial and fungal populations colonizing the scalp. PLoS One 8(3):e58203CrossRefPubMedPubMedCentral
11.
Keisha F, Julia O, Joy Y, Sean C, Clayton D, Meyer JA, Deborah S, Effie N, Morgan P, Kong HH (2013) Topographic diversity of fungal and bacterial communities in human skin. Nature 498(7454):367–370CrossRef
12.
Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA (2005) Diversity of the human intestinal microbial flora. Science 308(5728):1635–1638CrossRefPubMedPubMedCentral
13.
Perez Perez GI, Gao Z, Jourdain R, Ramirez J, Gany F, Clavaud C, Demaude J, Breton L, Blaser MJ (2016) Body site is a more determinant factor than human population diversity in the healthy skin microbiome. PLoS One 11(4):e0151990
14.
Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC, Bouffard GG, Blakesley RW, Murray PR, Green ED (2009) Topographical and temporal diversity of the human skin microbiome. Science 324(5931):1190–1192CrossRefPubMedPubMedCentral
15.
16.
Chiller K, Selkin BA, Murakawa GJ (2001) Skin microflora and bacterial infections of the skin. J Investig Dermatol Symp Proc 6(3):170–174CrossRefPubMed
17.
18.
Biedermann T (2006) Dissecting the role of infections in atopic dermatitis. Acta Dermato Venereologica 86(2):99–109PubMed
19.
Iwase T, Uehara Y, Shinji H, Tajima A, Seo H, Takada K, Agata T, Mizunoe Y (2010) Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature 465(7296):346–349CrossRefPubMed
20.
Lai Y, Di NA, Nakatsuji T, Leichtle A, Yang Y, Cogen AL, Wu ZR, Hooper LV, Schmidt RR, Von AS (2009) Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat Med 15(12):1377–1382CrossRefPubMedPubMedCentral
21.
Shu M, Wang Y, Yu J, Kuo S, Coda A, Jiang Y, Gallo RL, Huang CM (2013) Fermentation of Propionibacterium acnes, a commensal bacterium in the human skin microbiome, as skin probiotics against methicillin-resistant Staphylococcus aureus. PLoS One 8(2):1060–1064CrossRef
22.
Volz T, Skabytska Y, Guenova E, Chen KM, Frick JS, Kirschning CJ, Kaesler S, Röcken M, Biedermann T (2014) Nonpathogenic bacteria alleviating atopic dermatitis inflammation induce IL-10-producing dendritic cells and regulatory Tr1 cells. J Investig Dermatol 134(1):96–104CrossRefPubMed
23.
Lai Y, Cogen AL, Radek KA, Park HJ, Macleod DT, Leichtle A, Ryan AF, Nardo AD, Gallo RL (2010) Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections. J Investig Dermatol 130(9):2211–2221CrossRefPubMed
24.
Grice EA, Kong HH, Renaud G, Young AC, Bouffard GG, Blakesley RW, Wolfsberg TG, Turner ML, Segre JA (2008) A diversity profile of the human skin microbiota. Genome Res 18(7):1043–1050CrossRefPubMedPubMedCentral
25.
Sanmiguel A, Grice EA (2015) Interactions between host factors and the skin microbiome. Cellular Molecular Life Sci Cmls 72(8):1499–1515CrossRef
26.
27.
Flint HJ, Scott KP, Louis P, Duncan SH (2012) The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol 9(10):577–589CrossRefPubMed
28.
Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE (2006) Metagenomic analysis of the human distal gut microbiome. Science 312(5778):1355–1359CrossRefPubMedPubMedCentral
29.
Li J, Jia H, Cai X, Zhong H, Feng Q, Sunagawa S, Arumugam M, Kultima JR, Prifti E, Nielsen T (2014) An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol 32(8):834–841CrossRefPubMed
30.
Ley RE, Hamady M, Lozupone C, Turnbaugh PJ, Ramey RR, Bircher JS, Schlegel ML, Tucker TA, Schrenzel MD, Knight R (2008) Evolution of mammals and their gut microbes. Science 320(5883):1647–1651CrossRefPubMedPubMedCentral
31.
Consortium THMP (2012) Structure, function and diversity of the healthy human microbiome. Nature 486(7402):207–214CrossRef
32.
Paola MD, Filippo CD, Cavalieri D, Ramazzotti M, Poullet JB, Massart S, Collini S, Pieraccini G, Lionetti P (2010) PP90 impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 107(33):S445–S446
33.
Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP (2012) Human gut microbiome viewed across age and geography. Nature 486(7402):222–227CrossRefPubMedPubMedCentral
34.
Mardis ER, Gordon JI, Mahowald MA, Turnbaugh PJ, Ley RE, Magrini V (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444(7122):1027–1031CrossRefPubMed
35.
Koren O, Goodrich J, Cullender T, Spor A, Laitinen K, Bäckhed HK, Gonzalez A, Werner J, Angenent L, Knight R (2012) Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 150(3):470–480CrossRefPubMedPubMedCentral
36.
Mulders RJ, Git KCGD, Schéle E, Dickson SL, Sanz Y, Adan RAH (2018) Microbiota in obesity: interactions with enteroendocrine, immune and central nervous systems. Obes Rev 19(4)
37.
38.
Jobin C (2017) Human intestinal microbiota and colorectal cancer: moving beyond associative studies. Gastroenterology 153(6):1475–1478
39.
Round JL, Mazmanian SK (2010) Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 107(27):12204–12209CrossRefPubMedPubMedCentral
40.
41.
Abu-Shanab A, Quigley EM (2010) The role of the gut microbiota in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 7(12):691–701CrossRefPubMed
42.
Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI (2004) The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the United States of America 101 (44):15718–15723
43.
Fei N, Zhao L (2013) An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. Isme J Multidisciplinary J Microbial Ecology 7(4):880–884
44.
Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM (2013) Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A 110(22):9066–9071CrossRefPubMedPubMedCentral
45.
Gupta A, Madani R, Mukhtar H (2010) Streptococcus bovis endocarditis, a silent sign for colonic tumour. Color Dis 12(3):164–171CrossRef
46.
Viljoen KS, Dakshinamurthy A, Goldberg P, Blackburn JM (2015) Quantitative profiling of colorectal cancer-associated bacteria reveals associations between fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer. PLoS One 10(3):e0119462CrossRefPubMedPubMedCentral
47.
Ahn J, Sinha R, Pei Z, Dominianni C, Wu J, Shi J, Goedert JJ, Hayes RB, Yang L (2013) Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst 105(24):1907–1911CrossRefPubMedPubMedCentral
48.
Gonçalves P, Araújo JR, Di SJ (2018) A cross-talk between microbiota-derived short-chain fatty acids and the host mucosal immune system regulates intestinal homeostasis and inflammatory bowel disease. Inflamm Bowel Dis 24(3):558CrossRefPubMed
49.
50.
Consortium HMP (2012) Structure, function and diversity of the healthy human microbiome. Nature 486(7402):207–214CrossRef
51.
Wade WG (2012) The oral microbiome in health and disease. Pharmacological Research the Official Journal of the Italian Pharmacological Society 69 (1):137–143
52.
Crielaard W, Zaura E, Schuller AA, Huse SM, Montijn RC, Keijser BJ (2011) Exploring the oral microbiota of children at various developmental stages of their dentition in the relation to their oral health. BMC Med Genet 4(1):22
53.
Zheng H, Xu L, Wang Z, Li L, Zhang J, Zhang Q, Chen T, Lin J, Chen F (2015) Subgingival microbiome in patients with healthy and ailing dental implants. Sci Rep 5:10948
54.
Segal LN, Alekseyenko AV, Clemente JC, Kulkarni R, Wu B, Chen H, Berger KI, Goldring RM, Rom WN, Blaser MJ (2013) Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation. Microbiome 1(1):19CrossRefPubMedPubMedCentral
55.
Twigg HL, Morris A, Ghedin E, Curtis JL, Huffnagle GB, Crothers K, Campbell TB, Flores SC, Fontenot AP, Beck JM (2013) Use of bronchoalveolar lavage to assess the respiratory microbiome: signal in the noise. Lancet Respiratory Medicine 1(5):354–356CrossRefPubMed
56.
Venkataraman A, Bassis CM, Beck JM, Young VB, Curtis JL, Huffnagle GB, Schmidt TM (2015) Application of a neutral community model to assess structuring of the human lung microbiome. MBio 6(1)
57.
Dickson RP, Erbdownward JR, Freeman CM, Mccloskey L, Beck JM, Huffnagle GB, Curtis JL (2015) Spatial variation in the healthy human lung microbiome and the adapted island model of lung biogeography. Annals Am Thoracic Soc 12(6):821–830CrossRef
58.
Sze MA, Dimitriu PA, Hayashi S, Elliott WM, Mcdonough JE, Gosselink JV, Cooper J, Sin DD, Mohn WW, Hogg JC (2012) The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respiratory Critical Care Medicine 185(10):1073-1080CrossRef
59.
Zachariah R, Spielmann MP, Harries AD, Gomani P, Graham SM, Bakali E, Humblet P (2003) Passive versus active tuberculosis case finding and isoniazid preventive therapy among household contacts in a rural district of Malawi. Int J Tuberculosis Lung Disease 7(11):1033–1039
60.
Piters WAADS, Sanders EAM, Bogaert D (2015) The role of the local microbial ecosystem in respiratory health and disease. Philos Trans R Soc Lond 370(1675)
61.
Marri PR, Stern DA, Wright AL, Billheimer D, Martinez FD (2013) Asthma-associated differences in microbial composition of induced sputum. J Allergy Clinical Immunology 131(2):1–3CrossRef
62.
Garcianuñez M, Millares L, Pomares X, Ferrari R, Pérezbrocal V, Gallego M, Espasa M, Moya A, Monsó E (2014) Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease. J Clin Microbiol 52(12):4217–4223CrossRef
63.
Wu D, Hou C, Li Y, Zhao Z, Liu J, Lu X, Shang X, Xin Y (2014) Analysis of the bacterial community in chronic obstructive pulmonary disease sputum samples by denaturing gradient gel electrophoresis and real-time PCR. Bmc Pulmonary Medicine 14(1):179CrossRefPubMedPubMedCentral
64.
Han MK, Zhou Y, Murray S, Tayob N, Noth I, Lama VN, Moore BB, White ES, Flaherty KR, Huffnagle GB (2014) Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study. Lancet Respiratory Medicine 2(7):548–556CrossRefPubMed
65.
Dickson RP, ErbDownward JR, Huffnagle GB (2014) Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis. Lancet Respir Med 2(3):238–246CrossRefPubMedPubMedCentral
66.
Smith SB, Ravel J (2017) The vaginal microbiota, host defence and reproductive physiology. Journal of Physiology 595 (2):451-463
67.
Si J, You HJ, Yu J, Sung J, Ko G (2017) Prevotella as a hub for vaginal microbiota under the influence of host genetics and their association with obesity. Cell Host & Microbe 21(1):97–105
68.
Digiulio DB, Callahan BJ, Mcmurdie PJ, Costello EK, Lyell DJ, Robaczewska A, Sun CL, Goltsman DS, Wong RJ, Shaw G (2015) Temporal and spatial variation of the human microbiota during pregnancy. Proc Natl Acad Sci U S A 112(35):11060CrossRefPubMedPubMedCentral
69.
Bogaert D, Keijser B, Huse S, Rossen J, Veenhoven R, Gils EV, Bruin J, Montijn R, Bonten M, Sanders E (2011) Variability and diversity of nasopharyngeal microbiota in children: a metagenomic analysis. PLoS One 6(2):e17035CrossRefPubMedPubMedCentral
70.
Yan M, Pamp SJ, Fukuyama J, Hwang PH, Cho DY, Holmes S, Relman DA (2013) Nasal microenvironments and interspecific interactions influence nasal microbiota complexity and S. aureus carriage. Cell Host Microbe 14(6):631–640CrossRefPubMedPubMedCentral
71.
Yu J, Feng Q, Wong SH, Zhang D, Liang QY, Qin Y, Tang L, Zhao H, Stenvang J, Li Y (2017) Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut 66(1):70–78CrossRefPubMed
72.
Touchefeu Y, Montassier E, Nieman K, Gastinne T, Potel G, de Bruley VS, Vacon FL, La Cochetière MF (2014) Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis-current evidence and potential clinical applications. Alimentary Pharmacology Therapeutics 40(5):409–421PubMed
73.
Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, Qian Y, Kryczek I, Sun D, Nagarsheth N (2017) Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell 170(3):548–563CrossRefPubMedPubMedCentral
74.
Routy B, Le CE, Derosa L, Cpm D, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP (2018) Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359(6371):91–97CrossRefPubMed
75.
Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC (2018) Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359(6371):97–103CrossRefPubMed
76.
Matson V, Fessler J, Bao R, Chongsuwat T, Zha Y, Alegre ML, Luke JJ, Gajewski TF (2018) The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 359(6371):104–108CrossRefPubMed
77.
Chitapanarux I, Chitapanarux T, Traisathit P, Kudumpee S, Tharavichitkul E, Lorvidhaya V (2010) Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat Oncol 5(1):31CrossRefPubMedPubMedCentral
78.
Ciorba MA, Hallemeier CL, Stenson WF, Parikh PJ (2015) Probiotics to prevent gastrointestinal toxicity from cancer therapy: an interpretive review and call to action. Current Opinion Supportive Palliative Care 9(2):157–162CrossRef
79.
Blijlevens N, Donnelly JP, Pauw BD (2000) Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant 25(12):1269–1278CrossRefPubMed
80.
Montassier E, Gastinne T, Vangay P, Alghalith GA, Bruley dVS, Massart S, Moreau P, Potel G, Mf DLC, Batard E (2015) Chemotherapy-driven dysbiosis in the intestinal microbiome. Aliment Pharmacol Ther 42(5):515–528CrossRefPubMed
81.
Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillère R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ (2013) The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342(6161):971–976CrossRefPubMedPubMedCentral
82.
83.
Ciorba MA, Riehl TE, Rao MS, Clara M, Xueping E, Nava GM, Walker MR, Marinshaw JM, Stappenbeck TS, Stenson WF (2012) Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner. Gastroenterology 140(6):829–838
84.
Wang A, Ling Z, Yang Z, Kiela PR, Wang T, Wang C, Cao L, Geng F, Shen M, Ran X (2015) Gut microbial dysbiosis may predict diarrhea and fatigue in patients undergoing pelvic cancer radiotherapy: a pilot study. PLoS One 10(5):e0126312CrossRefPubMedPubMedCentral
85.
LloydPrice J, Mahurkar A, Rahnavard G, Crabtree J, Orvis J, Hall A, Brady A, Creasy H, McCracken C, Giglio M (2017) Strains, functions and dynamics in the expanded Human Microbiome Project. Nature 550(7674):61–66
Metadata
Title
How human microbiome talks to health and disease
Authors
Jing Cong
Xiaochun Zhang
Publication date
01-09-2018
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 9/2018
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-018-3263-1

Other articles of this Issue 9/2018

European Journal of Clinical Microbiology & Infectious Diseases 9/2018 Go to the issue

Original Article

Vitamin D supplementation to persistent carriers of MRSA—a randomized and placebo-controlled clinical trial

Original Article

Extremely and pandrug-resistant bacteria extra-deaths: myth or reality?

Original Article

Economic evaluation of micafungin versus liposomal amphotericin B (LAmB) for treating patients with candidaemia and invasive candidiasis (IC) in Turkey

Original Article

The nasopharyngeal microbiota in patients with viral respiratory tract infections is enriched in bacterial pathogens

Original Article

Detection of MRSA in nasal swabs—marked reduction of time to report for negative reports by substituting classical manual workflow with total lab automation

Correction

Correction to: Attitudes of physicians from 10 European countries on adherence and how treatment modalities in ABSSSI affect adherence: results from a Delphi survey
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits